Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.10.0.1
Stockholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2018:

 

   

Number

of options

   

Weighted-

average

exercise price

   

Weighted-

average

contractual

term (Yrs.)

 
Outstanding at December 31, 2017     77     $ 1,036,374       8  
Granted     -       -          
Expired     -       -          
Forfeit     -       -          
Exercised     -       -          
Outstanding at September 30, 2018     77     $ 1,036,374       8  
Exercisable at September 30, 2018     66     $ 1,186,581          

Schedule of Warrants Activity

The following summarizes the information related to warrants issued and the activity during the nine months ended September 30, 2018: 

 

    Number of warrants    

Weighted

average

exercise price

 
Balance at December 31, 2017     38,961,036     $ 2.48  
Warrants issued during the period     -     $ -  
Increases due to dilution     433,154,987     $ 0.67  
Warrants exercised during the period     (5,906,177 )   $ 0.17  
Warrants expired during the period     (2,760,079 )   $ -  
Balance at September 30, 2018     463,449,767     $ 0.21  

Schedule of Dilutive Effect of Common Shares

The following table presents the dilutive effect of our various potential common shares as of September 30, 2018:

 

    September 30, 2018  
Common shares outstanding     7,365,881  
Dilutive potential shares:        
Stock options     77  
Warrants     463,449,767  
Convertible debt     214,222,493  
Convertible preferred stock     68,344,495  
Total dilutive potential common shares, including outstanding common stock     753,382,713